Stem cell-based approaches for intervertebral disc regeneration

Current Stem Cell Research and Therapy

Volumn 6, Issue 4, 2011, Pages 317-326

  Huang, Shishu ^b   Tam, Vivian ^b   Cheung, Kenneth M C ^b   Long, Dan ^c   Minmin, L V ^c   Wang, Ting ^b   Zhou, Guangqian ^a,b,c  

^a SHENZHEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Cell biology; Cell therapy; Intervertebral disc; MSCs; Niche; Stem cell

Indexed keywords

ARTICLE; BONE REGENERATION; CELL THERAPY; CYTOLOGY; HOMEOSTASIS; HUMAN; INTERVERTEBRAL DISK; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 80055111343     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811797904335     Document Type: Article

References (107)

1. Roh JS, Teng AL, Yoo JU, et al. Degenerative disorders of the lumbar and cervical spine. Orthop Clin North Am 2005; 36: 255-262.
2. Larson JW, Levicoff EA, Gilbertson LG, et al. Biologic modification of animal models of intervertebral disc degeneration. J Bone Joint Surg Am 2006; 88: 83-7.
3. Louw QA, Morris LD, Grimmer-Somer K, et al. The prevalence of low back pain in Africa: a systematic review. BMC Musculoskelet Disord 2007; 8: 105.
4. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008; 8: 8-20.
5. Childs J, Fritz J, Flynn T, et al. A clinical predication rule to identify patients with low back pain most likely to benefit from spinal manipulation: A validation study. Annals of Internal Medicine 2004; 141: 920-8.
6. Zhou GQ, Yang F, Leung VL, Cheung KMC. Molecular and cellular biology of the intervertebral disc and the use of animal models. Curr Orthop 2008; 22: 267-273.
7. Schollmeier G, Lahr-Eigen R, Lewandrowski KU, et al. Observations on fiber-forming collagens in the anulus fibrosus. Spine 2000; 25: 2736-41.
8. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine 1995;20: 1307-14.
9. Hunter CJ, Matyas JR, Duncan NA. Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison. J Anat 2004; 205: 357-62.
10. Paesold G, Nerlich AG, Boos N. Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J 2007; 16: 447-68.
11. Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol 2002; 196: 374-9.
12. Walsh AJ, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine 2004; 29: 156-63.
13. Masuda K, Oegema TR Jr, An HS. Growth factors and treatment of intervertebral disc degeneration. Spine 2004; 29: 2757-69.
14. Masuda K, Imai Y, Okuma M, et al. Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine 2006; 31: 742-54.
15. Anderson DG, Tannoury C. Molecular pathogenic factors in symptomatic disc degeneration. Spine J 2005; 5: 260-6.
16. Leung VY, Chan D, Cheung KM. Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J 2006; 15: 406-13.
17. Humzah MD, Soames RW. Human intervertebral disc: structure and function. Anat Rec 1988; 220: 337-56.
18. Hunter C J, Matyas JR, Duncan NA. The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng 2003; 9: 667-77.
19. Goto S, Uhthoff HK. Notochord action on spinal development. A histologic and morphometric investigation. Acta Orthop Scand 1986; 57: 85-90.
20. Kim KW, Lim TH, Kim JG, Jeong ST, Masuda K, An HS. The origin of chondrocytes in the nucleus pulposus and histologic findings associated with the transition of a notochordal nucleus pulposus to a fibrocartilaginous nucleus pulposus in intact rabbit in-tervertebral discs. Spine 2003; 28: 982-90.
21. Gries NC, Berlemann U, Moore RJ, Vernon-Roberts B. Early his-tologic changes in lower lumbar discs and facet joints and their correlation. Eur Spine J 2000; 9: 23-9.
22. Mercer S, Bogduk N. The ligaments and annulus fibrosus of human adult cervical intervertebral discs. Spine 1999; 24: 619-26.
23. Hayes AJ, Benjamin M, Ralphs JR. Role of actin stress fibres in the development of the intervertebral disc: cytoskeletal control of extracellular matrix assembly. Dev Dyn 1999; 215: 179-89.
24. Adams MA, Dolan P, McNally DS. The internal mechanical functioning of intervertebral discs and articular cartilage, and its relevance to matrix biology. Matrix Biol 2009; 28: 384-9.
25. Lori A. Setton, Jun Chen. Intervertebral disc cell mechanics and biological responses to load. Curr Opin Orthop 2004; 15: 331-340.
26. Hu CJ, Wang LY, Chodosh LA, et al. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23: 9361-74.
27. Czyzyk-Krzeska MF, Meller J. Von Hippel-Lindau tumor suppressor: not only HIF's executioner. Trends Mol Med 2004; 10: 146-9.
28. Risbud MV, Guttapalli A, Stokes DG, et al. Nucleus pulposus cells express HIF-1alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment. J Cell Bio-chem 2006; 98: 152-9.
29. Agrawal A, Gajghate S, Smith H, et al. Cited2 modulates hypoxia-inducible factor-dependent expression of vascular endothelial growth factor in nucleus pulposus cells of the rat intervertebral disc. Arthritis Rheum 2008; 58: 3798-808.
30. Tsai TT, Guttapalli A, Agrawal A, et al. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the interverte-bral disc by transactivation of TonEBP/OREBP. J Bone Miner Res 2007; 22: 965-74.
31. Tsai TT, Danielson KG, Guttapalli A, et al. TonEBP/OREBP is a regulator of nucleus pulposus cell function and survival in the in-tervertebral disc. J Biol Chem 2006; 281: 25416-254.
32. Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular carti-lag. J Biol Chem 2007; 44: 32185-92.
33. Seki S, Kawaguchi Y, Chiba K, et al. A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nature Genetics 2005; 37: 607-12.
34. Song YQ, Cheung KM, Ho DW, et al. Association of the asporin D14 allele with lumbar-disc degeneration in Asians. Am J Hum Genet 2008; 82: 744-7.
35. Gruber HE, Ingram JA, Hoelscher GL, et al. Asporin, a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc. Arthritis Res Ther 2009; 11: 47.
36. Virtanen IM, Song YQ, Cheung KM, et al. Phenotypic and population differences in the association between CILP and lumbar disc disease. J Med Genet 2007; 44(4): 285-8.
37. Trout JJ, Buckwalter JA, Moore KC, Landas SK. Ultrastructure of the human intervertebral disc. I. Changes in notochordal cells with age. Tissue Cell 1982; 14: 359-69.
38. Roberts S, Evans EH, Kletsas D, et al. Senescence in human in-tervertebral discs. Eur Spine J 2006; 15: 312-6.
39. Gruber HE, Ingram JA, Norton HJ, et al. Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine 2007; 32: 321-7.
40. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degrada-tive enzymes and their inhibitors in the degenerate human interver-tebral disc. J Pathol 2004; 204: 47-54.
41. Le Maitre CL, Pockert A, Buttle DJ, et al. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans 2007; 35: 652-5.
42. Heathfield SK, Le Maitre CL, Hoyland JA. Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. Arthritis Res Ther 2008; 10: R87.
43. Crean JK, Roberts S, Jaffray DC, et al. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine 1997; 22: 2877-84.
44. Yamazaki S, Banes AJ, Weinhold PS, et al. Vibratory loading decreases extracellular matrix and matrix metalloproteinase gene expression in rabbit annulus cells. Spine J 2002; 2: 415-20.
45. Salo J, Mackiewicz Z, Indahl A, et al. Plasmin-matrix metallopro-teinase cascades in spinal response to an experimental disc lesion in pig. Spine 2008; 33: 839-44.
46. Iida R, Akeda K, Kasai Y, et al. Expression of proteinase-activated receptor-2 in the intervertebral disc. Spine 2009; 34: 470-8.
47. da Silva MR, Domingues CJ, Pinto RP, et al. New perspectives on degenerative disease treatment. Acta Reumatol Port 2009; 34: 327-35.
48. Mwale F, Wang HT, Zukor DJ, et al. Effect of a Type II Collagen Fragment on the Expression of Genes of the Extracellular Matrix in Cells of the Intervertebral Disc. Open Orthop J 2008; 2: 1-9.
49. Gruber HE, Ingram J, Leslie K, et al. Gene expressionn of types I, II, and VI collagen, aggrecan, and chondroitin-6-sulfotransferase in the human annulus: in situ hybridization findings. Spine J 2008; 8: 810-7.
50. Sztrolovics R, Alini M, Mort JS, Roughley PJ. Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine 1999; 24: 1765-71.
51. Wadhwa S, Embree MC, Kilts T, et al. Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthritis Cartilage 2005; 13: 817-27.
52. Tim Yoon S, Su Kim K, Li J, et al. The effect of bone morphoge-netic protein-2 on rat intervertebral disc cells in vitro. Spine 2003; 28: 1773-80.
53. Takae R, Matsunaga S, Origuchi N, et al. Immunolocalization of bone morphogenetic protein and its receptors in degeneration of in-tervertebral disc. Spine 1999; 24: 1397-401.
54. Wei A, Brisby H, Chung SA, Diwan AD. Bone morphogenetic protein-7 protects human intervertebral disc cells in vitro from apoptosis. Spine J 2008; 8: 466-74.
55. Taha MF. Cell Based-Gene Delivery Approaches for the Treatment of Spinal Cord Injury and Neurodegenerative Disorders. Curr Stem Cell Res Ther 2010; 5: 23-36.
56. Wuertz K, Godburn K, Neidlinger-Wilke C, Urban J, Iatridis JC. Behavior of mesenchymal stem cells in the chemical microenvi-ronment of the intervertebral disc. Spine 2008; 17: 1843-9.
57. Richardson SM, Hoyland JA. Stem cell regeneration of degenerated intervertebral discs: current status. Curr Pain Headache Rep 2008; 12: 83-8.
58. Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD. Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J 2008; 8: 888-96.
59. Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 2006; 27: 335-45.
60. Hiyama A, Mochida J, Iwashina T, et al. Transplantation of mesen-chymal stem cells in a canine disc degeneration model. J Orthop Res 2008; 26: 589-600.
61. Yang F, Leung VY, Luk KD, Chan D, Cheung KM. Mesenchymal stem cells arrest intervertebral disc degeneration through chondro-cytic differentiation and stimulation of endogenous cells. Mol Ther 2009; 17: 1959-66.
62. Le Maitre CL, Baird P, Freemont AJ, Hoyland JA. An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. Arthritis Res Ther 2009; 11: 20.
63. Nesti LJ, Li WJ, Shanti RM, et al. Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A 2008; 14: 1527-37.
64. Roughley P, Hoemann C, DesRosiers E, Mwale F, Antoniou J, Alini M. The potential of chitosan-based gels containing interver-tebral disc cells for nucleus pulposus supplementation. Biomateri-als 2006; 27: 388-96.
65. Ho G, Leung VY, Cheung KM, Chan D. Effect of severity of in-tervertebral disc injury on mesenchymal stem cell-based regeneration. Connect Tissue Res 2008; 49: 15-21.
66. Richardson SM, Curran JM, Chen R, et al. The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid [PLLA] scaffolds. Biomaterials 2006; 27: 4069-78.
67. Hoffmann A, Czichos S, Kaps C, et al. The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci 2002; 115: 769-81.
68. Richardson SM, Walker RV, Parker S, et al. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 2006; 24: 707-16.
69. Tapp H, Hanley EN Jr, Patt JC, Gruber HE. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med 2009; 234: 1-9.
70. Barclay WW, Axanova LS, Chen W, et al. Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation. Stem Cells 2008; 26: 600-10.
71. Gay IC, Chen S, MacDougall M. Isolation and characterization of multipotent human periodontal ligament stem cells. Orthod Craniofac Res 2007; 10: 149-60.
72. Bi Y, Driss Ehirchiou, Tina M Kilts, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007; 13: 1219-27.
73. Schnake KJ, Putzier M, Haas NP, Kandziora F. Mechanical concepts for disc regeneration. Eur Spine J 2006; 15: 354-60.
74. Johnson WE, Evans H, Menage J, Eisenstein SM, El Haj A, Roberts S. Immunohistochemical detection of Schwann cells in innervated and vascularized human intervertebral discs. Spine 2001; 26: 2550-7.
75. Haro H, Kato T, Komori H, Osada M, Shinomiya K. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herni-ated disc resorption. J Orthop Res 2002; 20: 409-15.
76. Risbud MV, Guttapalli A, Tsai TT, et al. Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine 2007; 32: 2537-44.
77. Henriksson H, Thornemo M, Karlsson C, et al. Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region. Spine 2009; 34: 2278-87.
78. Watanabe, T. The mechanism of transition from notochordal nucleus to fibrocartilagenous nucleus of the disc in the young monkey--an electron microscopic study. Nippon Seikeigeka Gakkai Zasshi 1983; 57: 519-32.
79. Kramer PA, Newell-Morris LL, Simkin PA. Spinal degenerative disk disease (DDD) in female macaque monkeys: epidemiology and comparison with women. J Orthop Res 2002; 20: 399-408.
80. Haifan Lin. The stem-cell niche theory: lessons from flies. Nature Reviews 2002; 3: 931-940.
81. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-6.
82. Giebel B, Bruns I. Self-renewal versus differentiation in hema-topoietic stem and progenitor cells: a focus on asymmetric cell divisions. Curr Stem Cell Res Ther 2008; 3: 9-16.
83. Chen XD, Dusevich V, Feng JQ, Manolagas SC, Jilka RL. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 2007; 22: 1943-56.
84. Mauney JR, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan DL. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A 2006; 79: 464-75.
85. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993; 122: 257-64.
86. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
87. Sawaguchi N, Majima T, Iwasaki N, et al. Extracellular matrix modulates expression of cell-surface proteoglycan genes in fibro-blasts. Connect Tissue Res 2006; 47: 141-8.
88. Senga K, Kobayashi M, Hattori H, et al. Type VI collagen in mouse masseter tendon, from osseous attachment to myotendinous junction. Anat Rec 1995; 243: 294-302.
89. Korhonen RK, Julkunen P, Wilson W, Herzog W. Importance of collagen orientation and depth-dependent fixed charge densities of cartilage on mechanical behavior of chondrocytes. J Biomech Eng 2008; 130: 021003.
90. Rui YF, Lui PP, Li G, Fu SC, Lee YW, Chan KM. Isolation and Characterization of Multi-potent Rat Tendon-derived Stem Cells. Tissue Eng Part A 2010; 16(5): 1549-58.
91. Zhang J, Wang JH. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J Orthop Res 2010; 28: 198-203.
92. Laurent Ameye, Dean Aria, Karl Jepsen, et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 2002; 16: 673-80.
93. Lechner BE, Lim JH, Mercado ML, Fallon JR. Developmental regulation of biglycan expression in muscle and tendon. Muscle Nerve 2006; 34: 347-55.
94. Harada H, Kettunen P, Jung HS, et al. Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. J Cell Biol 1999; 147: 105-20.
95. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004; 364: 149-55.
96. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 2004; 6: 422-32.
97. Nakayama N, Duryea D, Manoukian R, Chow G, Han CY. Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cells. J Cell Sci 2003; 116: 2015-28.
98. Djouad F, Delorme B, Maurice M, et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007; 9: 33.
99. Tare RS, Babister JC, Kanczler J, Oreffo RO. Skeletal stem cells: Phenotype, biology and environmental niches informing tissue regeneration. Mol Cell Endocrinol 2008; 288(1-2): 11-21.
100. Furukawa T, Ito K, Nuka S, et al. Absence of biglycan accelerates the degenerative process in mouse intervertebral disc. Spine 2009; 34: 911-7.
101. Wallach CJ, Sobajima S, Watanabe Y, et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 2003; 28: 2331-7.
102. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005; 7: 732-45.
103. Kim DJ, Moon SH, Kim H, et al. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 2003; 28: 2679-84.
104. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008; 453: 314-21.
105. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-46.
106. Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 2007; 4: 234.
107. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 2007; 109: 2688-92.